What are the possible causes of concurrent hyperferritinemia and elevated triglycerides?

Concurrent Hyperferritinemia and Elevated Triglycerides: Metabolic Syndrome and Fatty Liver Disease

The combination of elevated ferritin and triglycerides most commonly signifies metabolic syndrome with non-alcoholic fatty liver disease (NAFLD), where the hyperferritinemia reflects hepatocellular inflammation and insulin resistance rather than true iron overload. 1, 2

Primary Diagnostic Framework

Measure transferrin saturation (TS) immediately to distinguish true iron overload from inflammatory hyperferritinemia—this single test determines your entire diagnostic pathway. 1, 3

If Transferrin Saturation < 45%

• Iron overload is excluded with >90% certainty, and the elevated ferritin represents secondary causes rather than hereditary hemochromatosis. 1, 3
• The most likely diagnosis is NAFLD/metabolic syndrome, which accounts for over 90% of hyperferritinemia cases in outpatients when combined with other inflammatory conditions. 1, 3
• Ferritin elevation in NAFLD reflects hepatocellular injury and insulin resistance, not iron accumulation—approximately 30% of NAFLD patients have hyperferritinemia due to inflammation without hepatic iron overload. 1, 4
• Elevated triglycerides are a core component of metabolic syndrome and frequently coexist with hyperferritinemia in fatty liver disease. 2, 4

If Transferrin Saturation ≥ 45%

• Suspect primary iron overload and proceed immediately to HFE genetic testing for C282Y and H63D mutations. 1, 3
• C282Y homozygosity or C282Y/H63D compound heterozygosity confirms hereditary hemochromatosis, which can coexist with metabolic syndrome. 1, 3

Common Underlying Conditions

Metabolic Syndrome / NAFLD (Most Common)

• Ferritin is significantly correlated with insulin resistance and age in fatty liver patients, independent of actual iron stores. 1
• The European Association for the Study of the Liver recommends using complete iron profile (iron, TIBC, transferrin saturation, transferrin) rather than ferritin alone in overweight and obese individuals. 2
• Abdominal ultrasound should be performed to evaluate for fatty liver, which is found in nearly 40% of adults with abnormal liver parameters. 3
• Phlebotomy does not reduce triglycerides—a randomized controlled trial showed that iron depletion through repeated phlebotomies in patients with hyperferritinemia and hypertriglyceridemia did not reduce triglyceride concentration compared to diet alone. 5

Chronic Alcohol Consumption

• Chronic alcohol increases iron absorption and causes hepatocellular injury, leading to both elevated ferritin and triglycerides. 3
• Assess alcohol consumption history carefully, as alcoholic liver disease is a common cause of hyperferritinemia. 3

Dysmetabolic Iron Overload Syndrome (DIOS)

• A smaller subset of NAFLD patients develop DIOS, showing hyperferritinemia with mild iron accumulation in reticuloendothelial cells. 4
• DIOS can be treated with phlebotomy in selected cases if there is significant hepatic iron deposition on MRI. 6

Diagnostic Algorithm

1. Order fasting transferrin saturation, complete metabolic panel (AST, ALT), and inflammatory markers (CRP) to differentiate iron overload from inflammatory causes. 1, 3

2. If TS < 45% (most likely scenario):

   • Diagnose secondary hyperferritinemia from metabolic syndrome/NAFLD. 1, 3
   • Order abdominal ultrasound to confirm fatty liver. 3
   • Assess for metabolic risk factors: obesity, glucose intolerance, dyslipidemia. 3
   • Use non-invasive fibrosis scores (FIB-4 or NAFLD Fibrosis Score) to stratify risk. 3

3. If TS ≥ 45%:

   • Order HFE genetic testing for C282Y and H63D mutations. 1, 3
   • Consider liver MRI to quantify hepatic iron concentration if genetic testing is positive. 3

Risk Stratification by Ferritin Level

• Ferritin < 1,000 μg/L: Low risk of organ damage with 94% negative predictive value for advanced liver fibrosis. 1, 3
• Ferritin 1,000–10,000 μg/L: Higher risk of advanced fibrosis/cirrhosis if iron overload is present; consider liver biopsy if elevated liver enzymes or platelet count < 200,000/μL. 3
• Ferritin > 10,000 μg/L: Rarely represents simple iron overload; requires urgent specialist referral to evaluate for life-threatening conditions such as hemophagocytic lymphohistiocytosis or malignancy. 7, 8

Management Strategy

Treat the underlying metabolic condition, not the ferritin number itself. 1, 2

Primary Management

• Weight loss through caloric restriction and increased physical activity addresses the root cause of inflammation-driven ferritin elevation. 2
• Optimize glycemic control in diabetic patients, as diabetes is independently associated with higher ferritin levels even after controlling for BMI. 2
• Manage NAFLD with lifestyle modification, as hepatic steatosis contributes to both ferritin elevation and metabolic dysfunction. 2
• Monitor ferritin every 3 months as a marker of treatment response—declining ferritin indicates improvement in underlying inflammation and metabolic dysfunction. 1

When NOT to Use Phlebotomy

• Phlebotomy is ONLY indicated for confirmed iron overload with transferrin saturation ≥ 45% and evidence of end-organ damage. 1
• Do not perform therapeutic phlebotomy when TS < 45%, as this represents inflammatory hyperferritinemia where iron depletion will not improve outcomes. 1, 4, 5
• In the majority of NAFLD patients, hyperferritinemia is due to inflammation without hepatic iron overload, and phlebotomy is not effective. 4

Critical Pitfalls to Avoid

• Never use ferritin alone without transferrin saturation to diagnose iron overload—this leads to misdiagnosis and inappropriate phlebotomy. 1, 3
• Do not assume iron overload when transferrin saturation < 45%—over 90% of elevated ferritin cases are due to secondary causes. 1, 3
• Do not overlook chronic alcohol consumption as a cause of both hyperferritinemia and hypertriglyceridemia. 3
• Recognize that ferritin is an acute-phase reactant that rises during inflammation, liver disease, and tissue injury independent of actual iron levels. 1, 3

When to Refer to Hepatology

• Ferritin > 1,000 μg/L with elevated bilirubin or abnormal liver tests. 3
• Transferrin saturation ≥ 45% on repeat testing. 3
• Clinical evidence of cirrhosis (platelet count < 200,000/μL, elevated bilirubin, hepatomegaly). 3
• Ferritin continues rising despite treatment of metabolic syndrome. 3